Vitamin D Metabolism, Mechanism of Action, and Clinical Applications

被引:1478
作者
Bikle, Daniel D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Med & Dermatol, VA Med Ctr, San Francisco, CA 94121 USA
来源
CHEMISTRY & BIOLOGY | 2014年 / 21卷 / 03期
基金
美国国家卫生研究院;
关键词
D-RECEPTOR; PARATHYROID-HORMONE; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; ALPHA-HYDROXYLASE; CALCIUM SUPPLEMENTATION; EXTRARENAL SYNTHESIS; HUMAN KERATINOCYTES; NUCLEAR RECEPTOR; D; 25-HYDROXYLASE;
D O I
10.1016/j.chembiol.2013.12.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Vitamin D-3 is made in the skin from 7-dehydrocholesterol under the influence of UV light. Vitamin D-2 (ergocalciferol) is derived from the plant sterol ergosterol. Vitamin D is metabolized first to 25 hydroxyvitamin D (25OHD), then to the hormonal form 1,25-dihydroxyvitamin D (1,25(OH)(2)D). CYP2R1 is the most important 25-hydroxylase; CYP27B1 is the key 1-hydroxylase. Both 25OHD and 1,25(OH)(2)D are catabolized by CYP24A1. 1,25(OH)(2)D is the ligand for the vitamin D receptor (VDR), a transcription factor, binding to sites in the DNA called vitamin D response elements (VDREs). There are thousands of these binding sites regulating hundreds of genes in a cell-specific fashion. VDR-regulated transcription is dependent on comodulators, the profile of which is also cell specific. Analogs of 1,25(OH)(2)D are being developed to target specific diseases with minimal side effects. This review will examine these different aspects of vitamin D metabolism, mechanism of action, and clinical application.
引用
收藏
页码:319 / 329
页数:11
相关论文
共 124 条
[1]
CHARACTERIZATION OF 1-ALPHA-HYDROXYLATION OF VITAMIN-D3 STEROLS BY CULTURED ALVEOLAR MACROPHAGES FROM PATIENTS WITH SARCOIDOSIS [J].
ADAMS, JS ;
GACAD, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (04) :755-765
[2]
Control of autoimmune diseases by the vitamin D endocrine system [J].
Adorini, Luciano ;
Penna, Giuseppe .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (08) :404-412
[3]
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol) [J].
Adorini, Luciano ;
Penna, Giuseppe ;
Amuchastegui, Susana ;
Cossetti, Chiara ;
Aquilano, Francesca ;
Mariani, Roberto ;
Fibbi, Benedetta ;
Morelli, Annarnaria ;
Uskokovic, Milan ;
Colli, Enrico ;
Maggi, Mario .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :689-693
[4]
Expression of VDR and CYP24A1 mRNA in human tumors [J].
Anderson, MG ;
Nakane, M ;
Ruan, XA ;
Kroeger, PE ;
Wu-Wong, JR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) :234-240
[5]
[Anonymous], LANDSCOPE
[6]
Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells [J].
Armbrecht, HJ ;
Hodam, TL ;
Boltz, MA ;
Partridge, NC ;
Brown, AJ ;
Kumar, VB .
ENDOCRINOLOGY, 1998, 139 (08) :3375-3381
[7]
Fibroblast Growth Factor 23 Inhibits Extrarenal Synthesis of 1,25-Dihydroxyvitamin D in Human Monocytes [J].
Bacchetta, Justine ;
Sea, Jessica L. ;
Chun, Rene F. ;
Lisse, Thomas S. ;
Wesseling-Perry, Katherine ;
Gales, Barbara ;
Adams, John S. ;
Salusky, Isidro B. ;
Hewison, Martin .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (01) :46-55
[8]
Analytical measurement and clinical relevance of vitamin D3 C3-epimer [J].
Bailey, Dana ;
Veljkovic, Kika ;
Yazdanpanah, Mehrdad ;
Adeli, Khosrow .
CLINICAL BIOCHEMISTRY, 2013, 46 (03) :190-196
[9]
Vitamin D and the skin: Physiology and pathophysiology [J].
Bikle, Daniel D. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2012, 13 (01) :3-19
[10]
Bikle DD, 2010, NUTR HEALTH SER, P277, DOI 10.1007/978-1-60327-303-9_12